Galecto Inc (GLTO NASDAQ) stock market data APIs
$21.2523
2.04(9.6%)
as of March 18, 2026
Try our APIs with
free plan!
Galecto Inc Financial Data Overview
Price chart is built with
Anychart
Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.
Prev. Close
21.2523
Open
23.2904
High
23.8837
Low
20.1468
52 wk Range
2.01-38.3251
Market Cap
43 731 K
Shares Outstanding
1 593 K
EPS
-2.36
Beta
1.409
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Galecto Inc data using free add-ons & libraries
Get Galecto Inc Fundamental Data
Galecto Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -11 862 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-06
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Galecto Inc News
New
Galecto prices $275M stock offering
* Galecto (GLTO [https://seekingalpha.com/symbol/GLTO]) priced [https://seekingalpha.com/pr/20395145-galecto-announces-pricing-of-275-million-underwritten-public-offering] its previously announc...
Galecto Announces Pricing of $275 Million Underwritten Public Offering
BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with...
Wayfair upgraded, Instacart initiated: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...
Galecto appoints former Blueprint Medicines executives as COO and CMO
* Galecto (GLTO [https://seekingalpha.com/symbol/GLTO]) said on Tuesday it has appointed Sherwin Sattarzadeh as Chief Operating Officer and Dr. Becker Hewes as chief medical officer, effective Janua...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
